Metformin and reduced osteoarthritis risk
Patients taking metformin for Type 2 diabetes had a lower risk of developing osteoarthritis than did patients taking a sulfonylurea, according to a study published
Patients taking metformin for Type 2 diabetes had a lower risk of developing osteoarthritis than did patients taking a sulfonylurea, according to a study published
Researchers say about 1 in 10 individuals are now affected by autoimmune disorders and have revealed new clues on possible causes. There are more than
New findings from an extension of the landmark Diabetes UK-funded Diabetes Remission Clinical Trial (DiRECT) have revealed that nearly a quarter (23%) of participants who
Covid-19 can more than triple the chance of being diagnosed with Type 2 diabetes within a year of being infected, according to a new Canadian study.
Expectant mothers under the care of University Hospital Southampton (UHS) NHS Foundation Trust maternity services are set to be the first in the world to
A survey has suggested that more than 8 in 10 people (84%) people affected by eating disorders believe the introduction of calories on menus has
New research has confirmed that untreated hearing loss increases dementia risk in middle-aged and older adults. A large observational study from the United Kingdom showed
Biotech company Enthera Pharmaceuticals has started a clinical trial to evaluate its product, Ent001, is safe and tolerated. This will lay the groundwork for the
America’s Food and Drugs Administration (FDA) recently cleared for a phase 2 clinical trial a new drug for Type 1 diabetes which would be the
New research has revealed that taking short breaks from sitting can help people with Type 1 diabetes better manage their blood sugar levels. Sitting for